Genetic analysis of six subjects revealed an absence of myeloid differentiation primary response 88 (MYD88) or cluster ... of a better response to BTK inhibitors. Sellas Life Sciences CEO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback